Improving rheumatic fever surveillance in New Zealand: results of a surveillance sector review

BMC Public Health

Michael G Baker¹  Nevil Pierse¹  Jane Oliver¹ 

[1] University of Otago, PO Box 7343, 23A Mein Street, Newtown, Wellington 6242, New Zealand

关键词: Rheumatic heart disease;    Acute rheumatic fever;    Epidemiological surveillance;    Public health surveillance;   

Others  :  1130109
DOI  :  10.1186/1471-2458-14-528

 received in 2014-01-22, accepted in 2014-05-06,  发布年份 2014

【 摘 要 】

Background

The New Zealand (NZ) Government has made a strong commitment to reduce the incidence of rheumatic fever (RF) by two thirds, to 1.4 cases per 100,000, by mid-2017. We reviewed the NZ RF surveillance sector, aiming to identify potential improvements which would support optimal RF control and prevention activities.

Methods

This review used a recently developed surveillance sector review method. Interviews with 36 key informants were used to describe the sector, assess it and identify its gaps. Priorities for improvement and implementation strategies were determined following discussion with these key informants, with policy advisors and within the research team.

Results

Key improvements identified included the need for a comprehensive RF surveillance strategy, integrated reporting and an online national RF register. At a managerial level this review provided evidence for system change and built support for this across the surveillance sector.

Conclusions

The surveillance sector review approach can be added to the small set of tools currently available for developing and evaluating surveillance systems. This new approach is likely to prove useful as we confront the challenges of combating new emerging infectious diseases, responding to global environmental changes, and reducing health inequalities.

【 授权许可】

   
2014 Oliver et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Rammelkamp CH, Wannamaker LW, Denny FW: The Epidemiology and prevention of rheumatic fever. Bull N Y Acad Med 1952, 28(5):321-334.
• [2]Shea PR, Ewbank AL, Gonzalez-Lugo JH, Martagon-Rosado AJ, Martinez-Gutierrez JC, Rehman HA, Serrano-Gonzalez M, Fittipaldi N, Beres SB, Flores AR, Low DE, Willey BM, Musser JM: Group A Streptococcus emm gene types in pharyngeal isolates, Ontario, Canada, 2002–2010. Emerg Infect Dis 2011, 17(11):2010-2017.
• [3]Atatoa-Carr P, Lennon D, Wilson N: Rheumatic fever diagnosis, management, and secondary prevention: a New Zealand guideline. N Z Med J 2008, 121(1271):59-69.
• [4]Jaine R, Baker M, Venugopal K: Epidemiology of acute rheumatic fever in New Zealand 1996–2005. J Paediatr Child Health 2008, 44:564-571.
• [5]Milne RJ, Lennon DR, Stewart JM, Vander Hoorn S, Scuffham PA: Incidence of acute rheumatic fever in New Zealand children and youth. J Paediatr Child Health 2012, 48(8):685-691.
• [6]Jaine R, Baker MG, Venugopal K: Acute rheumatic fever associated with household crowding in a developed country. Paed Infect Dis J 2010, 30(4):315-319.
• [7]Better Public Services: Supporting Vulnerable children. Wellington: State Services Commission; 2012. [updated 2012 22 Aug 2012; cited 2012 17 Sep] Available from: [ http://www.ssc.govt.nz/bps-supporting-vulnerable-children webcite]
• [8]Atatoa-Carr P, Bell A, Lennon DR: Acute rheumatic fever in the waikato district health board region of New Zealand: 1998–2004. N Z Med J 2008, 121(1285):96-105.
• [9]Jackson C, Lennon D: Rheumatic fever register scoping the development of a national web-based rheumatic fever register. Ministry of Health: Auckland; 2009.
• [10]Moxon T, Lennon D, Reed P, Jackson C, Anderson A, Leversha A, Jelleyman T: Is A Rheumatic Fever Register the Best Way to Evaluate the Government Programme to Control Rheumatic Fever?. Auckland: Paper presented at the Paediatric Society of New Zealand 64th annual meeting; 2012.
• [11]Loring B: Rheumatic fever in the bay of plenty and lakes District Health Boards. A review of the evidence and recommendations for action. Summary Report. Toi te Ora Public Health; 2008.
• [12]Gray GC, Callahan JD, Hawksworth AW, Fisher CA, Gaydos JC: Respiratory diseases among US military personnel: countering emerging threats. Emerg Infect Dis 1999, 5(3):379-387.
• [13]Baker MG, Easther S, Wilson N: A surveillance sector review applied to infectious diseases at a country level. BMC Public Health 2010, 10:332. BioMed Central Full Text
• [14]Baker MG, Fidler DP: Global public health surveillance under new international health regulations. Emerg Infect Dis 2006, 12(7):1058-1065.
• [15]Crump JA, Murdoch DR, Baker MG: Emerging infectious diseases in an island ecosystem: the New Zealand perspective. Emerg Infect Dis 2001, 7(5):767-772.
• [16]Steer AC, Jenney A, Kado J, Good MF, Batzloff M, Waqatakirewa L, Mullholland EK, Carapetis JR: Prospective surveillance of invasive group a streptococcal disease, Fiji, 2005–2007. Emerg Infect Dis 2009, 15(2):216-222.
• [17]Yang P, Peng X, Zhang D, Wu S, Liu Y, Cui S, Lu G, Duan W, Shi W, Liu S, Li J, Wang Q: Characteristics of group A Streptococcus strains circulating during scarlet fever epidemic, Beijing, China, 2011. Emerg Infect Dis 2013, 19(6):909-915.
• [18]Goldstein E, Kirkcaldy RD, Reshef D, Berman S, Weinstock H, Sabeti P, Rio CD, Hall G, Hook EW, Lipsitch M: Factors related to increasing prevalence of resistance to ciprofloxacin and other antimicrobial drugs in Neisseria gonorrhoeae, United States. Emerg Infect Dis 2012, 18(8):1290-1297.
• [19]Braden CR, Dowell SF, Jernigan DB, Hughes JM: Progress in global surveillance and response capacity 10 years after severe acute respiratory syndrome. Emerg Infect Dis 2013, 19(6):864-869.
• [20]Centers for Disease Control and Prevention: Updated guidelines for evaluating public health surveillance systems: recommendations from the guidelines working group. MMWR 2001, 50:13.
• [21]National Minimum Dataset (hospital events). Wellington, New Zealand: Ministry of Health; 2012. [updated 2012 27 Apr 2012; cited 2012 13 Sep]; Available from: [ http://www.health.govt.nz/nz-health-statistics/national-collections-and-surveys/collections/national-minimum-dataset-hospital-events webcite]
• [22]Millen PG: The Infectious Disease Order 1986. The New Zealand Gazette, Volume 195 1986.
• [23]Communicable Disease Control Manual. 2012. [updated May 2012; cited 7 May 2013]; Available from: [ http://www.health.govt.nz/publication/communicable-disease-control-manual-2012 webcite]
• [24]Oliver J, Pierse N, Baker MG: Improving rheumatic fever surveillance in New Zealand. A report prepared for the ministry of health. New Zealand Ministry of Health: Wellington; 2013.
• [25]Yap M: Review: Rheumatic Fever Registers as a component of Secondary Prevention Programmes. New Zealand Ministry of Health: Wellington; 2012.
• [26]World Health Assembly: Revision of the international health regulations, WHA58.3. 2005. [updated 2005; cited 4 April 2012]; Available from: [ http://www.who.int/csr/ihr/WHA58-en.pdf webcite]
• [27]Ralph AP, Carapetis JR: Group a streptococcal diseases and their global burden. Curr Top Microbiol Immunol 2013, 368:1-27.
• [28]Carapetis JR, Steer AC, Mulholland EK, Weber M: The global burden of Group A streptococcal diseases. Lancet Infect Dis 2005, 5(11):685-694.